IFN-lambda 3, not IFN-lambda 4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis

Mohammed Eslam, Duncan McLeod, Kebitsaone Simon Kelaeng, Alessandra Mangia, Thomas Berg, Khaled Thabet, William L Irving, Gregory J Dore, David Sheridan, Henning Grønbæk, Maria Lorena Abate, Rune Hartmann, Elisabetta Bugianesi, Ulrich Spengler, Angela Rojas, David R. Booth, Martin Weltman, Lindsay Mollison, Wendy Cheng, Stephen RiordanHema Mahajan, Janett Fischer, Jacob Nattermann, Mark W Douglas, Christopher Liddle, Elizabeth Powell, Manuel Romero-Gomez, Jacob George*, Int Liver Dis Genetics Consortium

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisLetterpeer review


Genetic variation in the IFNL3-IFNL4 (interferon-lambda 3-interferon-lambda 4) region is associated with hepatic inflammation and fibrosis1-4. Whether IFN-lambda 3 or IFN-lambda 4 protein drives this association is not known. We demonstrate that hepatic inflammation, fibrosis stage, fibrosis progression rate, hepatic infiltration of immune cells, IFN-lambda 3 expression, and serum sCD163 levels (a marker of activated macrophages) are greater in individuals with the IFNL3-IFNL4 risk haplotype that does not produce IFN-lambda 4, but produces IFN-lambda 3. No difference in these features was observed according to genotype at rs117648444, which encodes a substitution at position 70 of the IFN-lambda 4 protein and reduces IFN-lambda 4 activity, or between patients encoding functionally defective IFN-lambda 4 (IFN-lambda 4-Ser70) and those encoding fully active IFN-lambda 4-Pro70. The two proposed functional variants (rs368234815 and rs4803217) 5,6 were not superior to the discovery SNP rs12979860 with respect to liver inflammation or fibrosis phenotype. IFN-lambda 3 rather than IFN-lambda 4 likely mediates IFNL3-IFNL4 haplotypedependent hepatic inflammation and fibrosis.

TidsskriftNature Genetics
Sider (fra-til)795-800
Antal sider8
StatusUdgivet - maj 2017


Dyk ned i forskningsemnerne om 'IFN-lambda 3, not IFN-lambda 4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis'. Sammen danner de et unikt fingeraftryk.